Caption Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $1.53 Million - $2 Million	38,600 New	38,600 $2 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $21.7 Million - $25.9 Million	-448,500 Reduced 89.97%	50,000 $2.57 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $11.6 Million - $12.9 Million	-200,000 Reduced 28.63%	498,500 $28.9 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $12.7 Million - $14.1 Million	200,000 Added 40.12%	698,500 $44.7 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $2.96 Million - $3.35 Million	-45,000 Reduced 8.28%	498,500 $34.6 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $33.8 Million - $40 Million	493,500 Added 987.0%	543,500 $39.1 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $980,370 - $1.08 Million	13,500 Added 36.99%	50,000 $3.85 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $2.24 Million - $2.69 Million	36,500 New	36,500 $2.67 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $16.1 Million - $18.8 Million	-300,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $10.2 Million - $11.9 Million	172,000 Added 134.38%	300,000 $17.8 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $53.8 Million - $58.6 Million	-869,200 Reduced 87.16%	128,000 $8.55 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $35.8 Million - $42.7 Million	792,800 Added 387.87%	997,200 $47.6 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $12.3 Million - $13.4 Million	204,400	204,400 $12.5 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.